In this certified ondemand webcast experts discuss the evolving management of ERpositiveHER2negative advanced breast cancer highlighting the role of ESR1 mutation testing emerging nextgeneration ERdirected therapies biomarkerdriven treatment sequencing after progression on a CDK46 inhibitor and practical strategies for optimizing safety adherence and patient outcomes
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
97% of listed courses are free
292 of a sample of 300 are free · 545 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.5 credits
- MOC · Up to 1.5 points
- Commercial Support
-
ReleasedJun 17, 2026
-
Last day to claim creditDec 17, 2026 2 months left
-
PRIME Education, Inc. (PRIME®) Clinical Evidence at the Edge of Resistance: Next-Generation SERDs for ESR1-Mutated Breast Cancer
-
Answers in CME Inc. (AiCME) Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer
-
University of Chicago School of Medicine Navigating Complexity in the Post-CDK4/6 Inhibitor Treatment Setting for Patients With ER+/HER2- mBC: Strategies for Optimally Integrating Next-Generation Oral SERDs
-
Clinical Care Options, LLC (dba Decera Clinical Education) Next-Generation Oral SERDs in Adjuvant ER-Positive/HER2-Negative Early Breast Cancer: Interrogating the Evidence for Clinical Integration
-
Clinical Care Options, LLC (dba Decera Clinical Education) Optimizing First-line Maintenance for HER2+ MBC: Equipping the Multidisciplinary Team With the Latest Evidence and Guidance on Novel Regimens
-
Clinical Care Options, LLC (dba Decera Clinical Education) Optimizing Treatment Sequencing in HER2-Positive Metastatic Breast Cancer
